FGF23 and chronic kidney disease: Most of the studies have shown that patients with CKD have a secondary increase in FGF23 due to high phosphate levels, which in turn affects the heart through various mechanisms, as Maren Leifheit-Nestler et al. state in their retrospective case-control study.